DIEVINI HOPP BIOTECH HOLDING
Dievini is an active investor in Life and Health Sciences companies and is dedicated to the coaching and support of the management teams in corporate and business development. Dievini’s focus is on innovative therapeutics and diagnostics, which are shown to lead to novel treatment regimens allowing doctors to treat patients with life-threatening diseases better and safer than they can today. Dievini, therefore, is largely invested in companies with unique and first-in-class diagnosis and ther... apy approaches. The indication focus is in oncology, neurology, infectious diseases, cell therapy and drug delivery systems. In molecular diagnostics, the primary focus is on systems and products in personalized medicine to support and allow individually improved therapy success with reduced adverse events. Dievini’s activities are geographically centered in Germany and Europe. The companies invested in are actively supported in their global development and business activities by dievini.
DIEVINI HOPP BIOTECH HOLDING
Industry:
Biotechnology Health Care Life Science Tutoring
Founded:
2005-01-01
Status:
Active
Contact:
+ 49 (0) 6227 8608 462
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail
Similar Organizations
European Society of Radiology
European Society of Radiology provides the technical platform that supports and licensing of digital consumable CDS.
Kurma Partners
Kurma Partners is a management company specializing in the financing of innovation in healthcare and biotechnology.
What If Ventures
What If Ventures invests primarily in mental health, addiction, and stigmatized healthcare services from seed stage to pre-IPO.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-07-17 | LTS Lohmann Therapie-Systeme AG | LTS Lohmann Therapie-Systeme AG acquired by dievini Hopp Biotech Holding | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-04-12 | Novaliq | dievini Hopp Biotech Holding investment in Venture Round - Novaliq | 13.9 M EUR |
| 2020-04-27 | Heidelberg Pharma AG | dievini Hopp Biotech Holding investment in Post-IPO Equity - Heidelberg Pharma AG | 14.4 M EUR |
| 2020-03-17 | immatics biotechnologies | dievini Hopp Biotech Holding investment in Post-IPO Equity - immatics biotechnologies | 104 M USD |
| 2020-01-22 | Heidelberg Pharma AG | dievini Hopp Biotech Holding investment in Post-IPO Equity - Heidelberg Pharma AG | 15 M EUR |
| 2018-10-11 | Novaliq | dievini Hopp Biotech Holding investment in Series F - Novaliq | 53 M USD |
| 2017-10-04 | immatics biotechnologies | dievini Hopp Biotech Holding investment in Series E - immatics biotechnologies | 58 M USD |
| 2015-11-16 | Molecular Health | dievini Hopp Biotech Holding investment in Private Equity Round - Molecular Health | 25 M EUR |
| 2015-11-03 | CureVac | dievini Hopp Biotech Holding investment in Series F - CureVac | 98.5 M EUR |
| 2014-07-16 | immatics biotechnologies | dievini Hopp Biotech Holding investment in Series D - immatics biotechnologies | 22 M EUR |
| 2014-01-09 | AC Immune | dievini Hopp Biotech Holding investment in Series D - AC Immune | 20 M CHF |